163 related articles for article (PubMed ID: 24581596)
1. Hepatic steatosis is associated with increased hepatic FDG uptake.
Keramida G; Potts J; Bush J; Dizdarevic S; Peters AM
Eur J Radiol; 2014 May; 83(5):751-5. PubMed ID: 24581596
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of (18)F-FDG in the liver in hepatic steatosis.
Keramida G; Potts J; Bush J; Verma S; Dizdarevic S; Peters AM
AJR Am J Roentgenol; 2014 Sep; 203(3):643-8. PubMed ID: 25148170
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of intrahepatic fat distribution determined by (18)F-FDG PET and CT.
Keramida G; Hunter J; Dizdarevic S; Peters AM
Ann Nucl Med; 2016 Apr; 30(3):200-6. PubMed ID: 26768891
[TBL] [Abstract][Full Text] [Related]
4. Quantification of tumour (18) F-FDG uptake: Normalise to blood glucose or scale to liver uptake?
Keramida G; Dizdarevic S; Bush J; Peters AM
Eur Radiol; 2015 Sep; 25(9):2701-8. PubMed ID: 25899414
[TBL] [Abstract][Full Text] [Related]
5. Relationships of body habitus and SUV indices with signal-to-noise ratio of hepatic (18)F-FDG PET.
Keramida G; Dunford A; Siddique M; Cook GJ; Peters AM
Eur J Radiol; 2016 May; 85(5):1012-5. PubMed ID: 27130064
[TBL] [Abstract][Full Text] [Related]
6. Hepatic and splenic
Keramida G; Roldao Pereira L; Kaya G; Peters AM
Clin Physiol Funct Imaging; 2020 Mar; 40(2):99-105. PubMed ID: 31769591
[TBL] [Abstract][Full Text] [Related]
7. Effect of hepatic steatosis on liver FDG uptake measured in mean standard uptake values.
Abele JT; Fung CI
Radiology; 2010 Mar; 254(3):917-24. PubMed ID: 20177102
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG uptake and clearance in patients with compromised renal function.
Akers SR; Werner TJ; Rubello D; Alavi A; Cheng G
Nucl Med Commun; 2016 Aug; 37(8):825-32. PubMed ID: 27058366
[TBL] [Abstract][Full Text] [Related]
9. Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI.
Heusch P; Buchbender C; Beiderwellen K; Nensa F; Hartung-Knemeyer V; Lauenstein TC; Bockisch A; Forsting M; Antoch G; Heusner TA
Eur J Radiol; 2013 May; 82(5):870-6. PubMed ID: 23394765
[TBL] [Abstract][Full Text] [Related]
10. Methodologic Considerations for Quantitative 18F-FDG PET/CT Studies of Hepatic Glucose Metabolism in Healthy Subjects.
Trägårdh M; Møller N; Sørensen M
J Nucl Med; 2015 Sep; 56(9):1366-71. PubMed ID: 26159590
[TBL] [Abstract][Full Text] [Related]
11. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
[TBL] [Abstract][Full Text] [Related]
12. Variability and reproducibility of hepatic FDG uptake measured as SUV as well as tissue-to-blood background ratio using positron emission tomography in healthy humans.
Kanstrup IL; Klausen TL; Bojsen-Møller J; Magnusson P; Zerahn B
Clin Physiol Funct Imaging; 2009 Apr; 29(2):108-13. PubMed ID: 19076727
[TBL] [Abstract][Full Text] [Related]
13. Influences of point-spread function and time-of-flight reconstructions on standardized uptake value of lymph node metastases in FDG-PET.
Akamatsu G; Mitsumoto K; Taniguchi T; Tsutsui Y; Baba S; Sasaki M
Eur J Radiol; 2014 Jan; 83(1):226-30. PubMed ID: 24144448
[TBL] [Abstract][Full Text] [Related]
14. Standardized uptake value of normal organs on routine clinical [18F]FDG PET/CT: impact of tumor metabolism and patient-related factors.
Sharma P; Chatterjee P; Alvarado LA; Dwivedi AK
Nucl Med Rev Cent East Eur; 2023; 26(0):1-10. PubMed ID: 36286203
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of hepatic metabolic activity in non-alcoholic fatty livers on 18FDG PET/CT.
Dostbil Z; Varoğlu E; Serdengeçti M; Kaya B; Onder H; Sari O
Rev Esp Med Nucl Imagen Mol; 2013; 32(3):156-61. PubMed ID: 23177332
[TBL] [Abstract][Full Text] [Related]
16. Is liver SUV stable over time in ¹⁸F-FDG PET imaging?
Laffon E; Adhoute X; de Clermont H; Marthan R
J Nucl Med Technol; 2011 Dec; 39(4):258-63. PubMed ID: 21878481
[TBL] [Abstract][Full Text] [Related]
17. Altered hepatic metabolic activity in patients with hepatic steatosis on FDG PET/CT.
Abikhzer G; Alabed YZ; Azoulay L; Assayag J; Rush C
AJR Am J Roentgenol; 2011 Jan; 196(1):176-80. PubMed ID: 21178064
[TBL] [Abstract][Full Text] [Related]
18. Influence of Statistical Fluctuation on Reproducibility and Accuracy of SUVmax and SUVpeak: A Phantom Study.
Akamatsu G; Ikari Y; Nishida H; Nishio T; Ohnishi A; Maebatake A; Sasaki M; Senda M
J Nucl Med Technol; 2015 Sep; 43(3):222-6. PubMed ID: 26271802
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP
Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018
[TBL] [Abstract][Full Text] [Related]
20. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M
Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
